Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2018

01-04-2018 | Images

Extensive Platelet Phagocytosis in a Patient with Immune Thrombocytopenia (ITP) and Concomitant Tuberculosis

Authors: Naveen Kakkar, Preethi Paul, M. Joseph John, Amrith Mathew

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2018

Login to get access

Excerpt

Hemophagocytic syndrome is characterized by benign proliferation of mature histiocytes and uncontrolled phagocytosis of the erythrocytes, leukocytes, platelets and/or their hematopoietic precursors in the bone marrow. Hemophagocytic syndrome can be familial or acquired which is associated with tuberculosis, autoimmune disorders, hematologic malignancies or solid cancers [1]. Although histiocytes in the bone marrow may show phagocytosis of any of the hematopoietic precursors, marked platelet specific phagocytosis is an extremely rare finding. Inhibitory CD47/(signal regulatory protein) SIRP alpha signaling is involved in regulating platelet phagocytosis in ITP [2]. We present a patient with ITP who had concomitant tuberculosis and showed predominant platelet phagocytosis. A 61 years old male with ITP on steroid therapy presented with fever and cough since 2 weeks. He had pallor with no petechiae or purpuric spots. Investigations showed hemoglobin of 102 g/l with normal white cell count and thrombocytopenia (platelets: 58 × 109/l). Bone marrow aspiration showed increase in histiocytes with many of them showing extensive platelet phagocytosis (Fig. 1). Occasional histiocytes also showed erythroblastic phagocytosis (Fig. 1, Inset). Trephine biopsy and clot section showed epithelioid cell granulomata (Fig. 2a, b). Ziehl–Neelsen stain for acid fast bacilli was positive. HRCT chest was suggestive of military tuberculosis. The patient was started on anti-tubercular treatment and was discharged in a stable condition.
Literature
1.
go back to reference Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC (2006) Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis 6:447–454CrossRefPubMed Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC (2006) Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis 6:447–454CrossRefPubMed
2.
go back to reference Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg PA (2005) Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 105:3577–3582CrossRefPubMedPubMedCentral Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg PA (2005) Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 105:3577–3582CrossRefPubMedPubMedCentral
Metadata
Title
Extensive Platelet Phagocytosis in a Patient with Immune Thrombocytopenia (ITP) and Concomitant Tuberculosis
Authors
Naveen Kakkar
Preethi Paul
M. Joseph John
Amrith Mathew
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0874-0

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine